GE HealthCare announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care. The company said, "CARESCAPE Canvas and CARESCAPE ONE are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GEHC: